Article
Evaluation of a didanosin-containing regimen including genotypic resistance testing: an open-label, multicenter study.
European journal of medical research - 29 Sept 2003
Treichel Simone, Hartmann M, Rump A, Brust J, Schuster D, Mosthaf F, Procaccianti M, Klinker H, Petzoldt D
Abstract excerpt
PURPOSE: To show Didanosin in a new formulation as a once-a-day capsula as a well-tolerated and effective HIV-therapy when used in a protease sparing regimen including genotypic resistance pattern in blood, semen and cerebrospinal fluid before and during treatment. METHOD: Two groups of 58 patients, each containing 9 patients who had not been previously treated with any antiretroviral medication, and 49 patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.